Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5656 to 5670 of 8223 results

  1. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and calcium channel blockers, including compared with placebo, for adults with aortic regurgitation?

    Recommendation ID NG208/15 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  2. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with primary severe mitral regurgitation?

    Recommendation ID NG208/16 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  3. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with severe aortic stenosis?

    Recommendation ID NG208/14 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  4. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    Recommendation ID NG215/09 Question Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture

    Research recommendation
    Published
    11 May 2022

  5. Intensive rehabilitation therapies after hip fracture: What is the clinical and cost effectiveness of additional intensive physiotherapy and/or occupational therapy (for example, progressive resistance training) after hip fracture?

    Recommendation ID CG124/04 Question Intensive rehabilitation therapies after hip fracture: What is the clinical and cost effectiveness

    Research recommendation
    Published
    3 February 2023

  6. What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the surgical site compared with a single application?

    Recommendation ID NG125/8 Question What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the

    Research recommendation
    Published
    26 October 2020

  7. Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment target relative to the standard blood pressure treatment target for people with aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/12 Question Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment

    Research recommendation
    Published
    12 December 2022

  8. Auto- versus fixed-level CPAP for OSAHS: What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing mild obstructive sleep apnoea/hypopnoea syndrome (OSAHS)?

    Recommendation ID NG202/1 Question Auto- versus fixed-level CPAP for OSAHS: What is the clinical and cost effectiveness of auto- and fixed-level

    Research recommendation
    Published
    30 September 2021

  9. What is the clinical and cost effectiveness of alternative treatments as firstline treatment for trigeminal neuralgia compared with other better-tolerated pharmacological treatments?

    Recommendation ID CG173/10 Question What is the clinical and cost effectiveness of alternative treatments as firstline treatment for trigeminal

    Research recommendation
    Published
    26 October 2020

  10. Analgesics:- What is the clinical and cost effectiveness of analgesic drugs other than non-steroidal antiinflammatory drugs (NSAIDs) in adults with rheumatoid arthritis (RA) whose pain or stiffness control is not adequate?

    Recommendation ID NG100/1 Question Analgesics:- What is the clinical and cost effectiveness of analgesic drugs other than non-steroidal

    Research recommendation
    Published
    11 December 2018

  11. What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing moderate and severe OSAHS?

    Recommendation ID NG202/2 Question What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure

    Research recommendation
    Published
    30 September 2021

  12. Aspirin prophylaxis for people with fragility fractures of the pelvis, hip or proximal femur:- What is the clinical and cost effectiveness of aspirin alone versus other pharmacological and/or mechanical prophylaxis strategies (alone or in combination) for people with fragility fractures of the pelvis, hip or proximal femur?

    Recommendation ID NG89/4 Question Aspirin prophylaxis for people with fragility fractures of the pelvis, hip or proximal femur:- What is

    Research recommendation
    Published
    15 November 2018

  13. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of beta‑blockers for adults over 75 years with non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation?

    Recommendation ID NG208/17 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  14. What is the clinical and cost effectiveness of augmentative communication devices for autistic adults?

    Recommendation ID CG142/3 Question What is the clinical and cost effectiveness of augmentative communication devices for autistic adults

    Research recommendation
    Published
    10 August 2021

  15. What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in adults, young people and children?

    Recommendation ID NG191/9 Question What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in

    Research recommendation
    Published
    12 November 2021